Effects of methylprednisolone administration in acute myocardial infarction.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002339:Carotid Arteries / Q000187:drug effects; D002415:Cats; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D006352:Heart Ventricles / Q000201:enzymology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000494:pharmacology; D008026:Ligation; D008297:Male; D008643:Mesentery / Q000187:drug effects; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D012077:Renal Artery / Q000187:drug effects; D013268:Stimulation, Chemical
D000262:Adenylyl Cyclases; D007545:Isoproterenol; D010100:Oxygen; D002118:Calcium; D008775:Methylprednisolone